Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferoxamine and Xingnaojing for ICH
NCT02367248Phase 2Unknown
- Sponsor
- Capital Medical University
- Start
- Mar 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deferoxamine, Xingnaojing injection in intracerebral hemorrhage (ICH), sponsored by Capital Medical University. Status: unknown.
02
Drugs
deferoxamineXingnaojing injection
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT02367248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02367248.